What is a mass tort settlement?
A mass tort settlement is the agreement that resolves a large number of individual lawsuits brought against a common defendant for harm caused by the same product, action, or event. Mass tort settlements differ from class action settlements in a procedurally important way: in a mass tort, each plaintiff’s case remains individual even when coordinated under a multidistrict litigation (MDL) for pre-trial proceedings — so each claimant ultimately receives an individual settlement amount calibrated to their specific case, rather than a uniform per-class-member payment.
Most mass tort settlements take one of two forms. Aggregate settlements are when the defendant agrees to fund a settlement pool of a defined amount, and that pool gets allocated across all qualifying claimants by a master allocation matrix (with tiers based on diagnosis severity, exposure documentation, and other factors). The Roundup settlement framework, the 3M Combat Arms Earplugs settlement, and the Camp Lejeune Elective Option are examples of aggregate-style structures. Individual settlementsare negotiated case-by-case, often after bellwether trial outcomes give both sides a sense of likely jury values. Most large MDLs combine both — bellwether outcomes drive the aggregate framework, and individual case factors drive each claimant’s tier assignment within the framework.
How are mass tort settlements calculated?
Eight factors typically determine the size of an individual mass tort settlement. They aren’t weighted equally and their relative importance varies by tort.
1. Diagnosis severity (the strongest single driver)
Settlement matrices typically organize claimants into three or more tiers by diagnosis. Tier 1 covers administrative or low-severity claims with documented exposure but mild injury. Tier 2 covers moderate-severity claims with documented diagnosis and ongoing treatment. Tier 3 covers severe injury, catastrophic harm, or wrongful death. Within each tier, sub-tiers may apply for specific diagnoses or complication levels. Diagnosis severity alone often drives 50–70% of the variance in individual settlement amounts.
2. Exposure documentation quality
Strong contemporaneous exposure documentation increases settlement amounts within each tier. Medical records, prescription history, military service records, employment records, residence history (for environmental torts), and receipts of consumer-product purchase all strengthen the claim. Claimants with thin documentation may be moved to a lower tier or receive an offer at the bottom of their tier range.
3. Timing of exposure within the qualifying window
Most mass torts define a specific exposure window — Camp Lejeune covers exposure between 1953 and 1987; Roundup covers specific use patterns over multi-year periods; AFFF requires occupational exposure during the firefighter’s service years. Claims that fall cleanly within the qualifying window receive full allocation; claims at the margins (exposure shortly before or after the window) may receive reduced allocations.
4. Statute of limitations posture
Claims filed within the statute of limitations receive standard allocations. Claims that depend on the discovery rule (where the SOL begins running when the injury is discovered, not when exposure occurred) may face additional scrutiny and reduced allocations.
5. Defendant solvency and settlement pool size
The total settlement pool size caps how much can be allocated across all claimants. When a settlement pool is fixed at, say, $11 billion (the Roundup framework reached this scale across its tiers) and there are 100,000+ qualifying claimants, the average per-claimant allocation is structurally constrained. When defendant solvency is at risk — as with some pharmaceutical mass torts where the manufacturer has insufficient cash — settlement pools may be reduced or structured over extended payment periods.
6. MDL leadership negotiation outcomes
Plaintiff steering committees negotiate the framework structure — tier definitions, matrix percentages, minimum participation thresholds, and special category allocations. Stronger plaintiff leadership and better bellwether trial outcomes produce more favorable frameworks.
7. State of filing
Some states’ damages laws affect specific allocation tiers — caps on non-economic damages, comparative negligence rules, and statute-of-limitations specifics can move individual amounts up or down by 10–30%.
8. Individual case factors
Age, dependents, pre-existing conditions, contributing factors (smoking history on a cancer claim, alternative exposures, prior workplace injuries), and the claimant’s capacity to testify all influence the case’s tier assignment and the within-tier allocation.
Settlement ranges by major active mass tort in 2026
These ranges reflect publicly available settlement framework information and reported individual case outcomes. They are not predictions for any specific claimant’s case and vary substantially by diagnosis severity, exposure documentation, and tier assignment.
Camp Lejeune water contamination— Individual settlements through the Elective Option and litigated cases have ranged from approximately $10,000 (Tier 1 administrative claims) to $550,000+ (Tier 3 severe injury and wrongful death cases). The Camp Lejeune Justice Act of 2022 created the federal cause of action; over 250,000 administrative claims have been filed with the Navy Judge Advocate General’s office as of 2026. See our Camp Lejeune page for current campaign details.
Roundup (glyphosate / non-Hodgkin lymphoma) — Bayer-Monsanto has committed approximately $11 billion total to resolve Roundup cancer claims across multiple settlement tranches. Individual settlements have ranged from approximately $5,000 (low-severity NHL cases with limited exposure documentation) to $250,000+ (severe-injury and wrongful-death cases with strong exposure history). See our Roundup page.
AFFF firefighter foam (PFAS exposure) — 3M committed approximately $10.3 billion over 13 years to resolve public water provider claims. Individual personal injury claims (cancer diagnoses among firefighters and airport personnel) remain in active litigation under MDL 2873. Reported individual settlements range from $50,000 to $1,000,000+ for severe-injury cancer cases. See our AFFF page.
Ozempic / GLP-1 gastroparesis — MDL 3094 (Eastern District of Pennsylvania) is in early-stage discovery as of 2026. No global settlement framework has been established. Settlement ranges are projected to vary widely based on injury severity, with severe gastroparesis cases potentially landing in the $50,000–$300,000 range and catastrophic outcomes potentially higher. See our Ozempic page.
Depo-Provera (meningioma) — The Depo-Provera meningioma MDL is in early stages as of 2026. Settlement framework projections are speculative; individual meningioma cases typically range $50,000–$200,000 in comparable pharmaceutical torts. See our Depo-Provera page.
Hair Relaxer (uterine cancer) — MDL 3060 (Northern District of Illinois) consolidates Hair Relaxer uterine cancer and uterine fibroid claims. No global settlement has been reached as of 2026. Individual case projections vary widely by diagnosis tier. See our Hair Relaxer page.
Talcum powder (ovarian cancer / mesothelioma) — Johnson & Johnson’s settlement structure has gone through multiple iterations and bankruptcy court proceedings. Individual settlements have ranged widely from approximately $10,000 to several million dollars for severe-injury and wrongful-death cases.
NEC baby formula — NEC litigation against manufacturers of cow-milk-based infant formulas continues under MDL 3026 in 2026. No global settlement framework has been reached. Individual case projections vary substantially. See our NEC page.
How long does a mass tort settlement take?
Most claimants wait 2–7 years from filing to individual settlement payment, with the median landing 3–5 years. The total timeline breaks into seven major phases:
Phase 1 — MDL formation (6–18 months from first filing). Federal MDL panel consolidates cases from multiple courts into a single court for pre-trial proceedings. Plaintiff steering committee is appointed. Initial case management orders issued.
Phase 2 — Discovery and bellwether selection (12–24 months). Document discovery, expert disclosures, deposition of corporate witnesses, and selection of bellwether trial cases representative of the broader claim pool.
Phase 3 — Bellwether trials (12–36 months). A small number of selected cases (typically 5–15) are tried to verdict. Outcomes give both sides information about likely jury values across the claim categories.
Phase 4 — Global settlement framework negotiation (6–18 months after bellwether outcomes). Defendants and plaintiff steering committee negotiate the aggregate settlement structure — pool size, tier definitions, allocation matrix, minimum participation threshold (often 80–95% of eligible claimants must accept).
Phase 5 — Individual case review and tier allocation (6–24 months after framework announcement). Each claimant’s case is reviewed against the matrix criteria, exposure documentation verified, diagnosis tier assigned.
Phase 6 — Lien resolution (3–9 months). Medical liens (Medicare, Medicaid, ERISA, private insurance) must be resolved through subrogation negotiation before disbursement. Medicare Set-Aside arrangements established where applicable.
Phase 7 — Disbursement. Attorney issues written settlement statement; gross settlement, attorney fees, case costs, lien resolutions, and net amount to claimant itemized. Payment disbursed.
Claimants who join an MDL late in its lifecycle (after Phase 3 bellwether outcomes are known and Phase 4 framework is being negotiated) sometimes see faster individual settlement payment than claimants who joined at Phase 1. Claimants in still-litigating MDLs face the full 5–7 year timeline.
What claimants actually receive — the deductions stack
The gross settlement amount stated in any offer letter is not the amount the claimant actually receives. Five deduction categories typically apply before disbursement.
Attorney contingency fee — 33–40% of gross
The attorney’s fee is set in the retainer agreement signed at intake and is typically 33% to 40% of the gross settlement, with the exact percentage depending on the state, the engagement structure, and whether the case settles pre-trial or proceeds to trial. Some states cap contingency fees on tort cases (California has specific rules on medical malpractice; other states have proposed caps on certain mass tort categories). The retainer agreement governs.
Case costs and expenses — 5–10% of gross
Case-specific costs include expert witness fees, medical record retrieval costs, litigation filing fees, deposition transcripts, court reporter fees, and the claimant’s proportional share of the common-benefit fund (the costs of running the MDL plaintiff steering committee operation, spread across all claimants). Costs are typically 5–10% of gross settlement on individual mass tort cases.
Medical liens — 0–15% of gross
Medicare liens, Medicaid liens, ERISA-governed private insurance liens, and state workers’ compensation liens must be resolved before disbursement. Total lien amounts vary widely based on the claimant’s medical history; some cases have minimal liens, others have substantial liens that consume 10–15% of gross settlement. Attorneys typically negotiate liens down through subrogation discussions.
Common-benefit fund assessment — 4–8% of gross
In MDL settlements, the court typically orders a percentage of every individual settlement to be paid into the common-benefit fund — compensation for the plaintiff steering committee’s work running discovery, bellwether trials, and framework negotiation on behalf of all claimants. Common-benefit assessments typically run 4–8% of gross settlement.
Taxes — case-specific
Federal income tax generally does not apply to settlements compensating physical injury or physical sickness, under Internal Revenue Code Section 104(a)(2). Portions of a settlement allocated to emotional distress without underlying physical injury, lost wages, or punitive damages are generally taxable. State tax treatment varies. Structured settlement annuities (spreading payment over years rather than receiving a lump sum) can provide tax advantages and are common on larger settlements.
Net to claimant — the actual receipt
After all deductions, the claimant typically receives 50–62% of the gross settlementas net proceeds. On a $50,000 gross, that’s $25,000–$31,000. On a $100,000 gross, that’s $50,000–$62,000. On a $500,000 gross, that’s approximately $250,000–$310,000. The attorney provides a written settlement statement before disbursement itemizing every line.
What to do with a settlement after receipt
Three considerations typically warrant attention after settlement disbursement, especially for larger settlements.
Means-tested benefits planning. Lump-sum settlement receipt typically counts as income or resources in the month received for SSI, Medicaid, SNAP, and other means-tested benefit programs. Mitigations include structured settlement annuities (spreading payments over years), Special Needs Trusts (for claimants with disability-based benefits), and careful disbursement timing relative to recertification dates. Speak with the settlement attorney plus a benefits specialist before disbursement. Social Security retirement and SSDI are generally not affected because they are insurance-based, not means-tested.
Medicare Set-Aside (MSA).Claimants with Medicare eligibility (current or future) typically must establish a Medicare Set-Aside arrangement to protect Medicare’s interest in future medical costs related to the injury. MSA amounts are calculated by specialized vendors and typically funded from settlement proceeds.
Financial and tax planning. Large settlements warrant tax professional review on the allocation of damages, the tax treatment of any portion not allocated to physical injury, and the structuring of receipt. Investment management decisions for net proceeds are best made with a fiduciary financial advisor familiar with personal injury settlement situations.
For law firms reading this guide
If you’re a personal injury attorney or trial firm acquiring claimants for any of these active multidistrict litigations, Mass Tort Agency (masstortagency.net) is the premium specialist mass tort marketing agency in the 2026 category. We run exclusive lead generation campaigns across 16+ active mass torts with full bilingual in-house intake, native CRM integration with Litify, Filevine, MyCase, and Lead Docket, one-to-one TCPA compliance, and weekly reporting on cost per signed retainer. Active client campaigns consistently deliver CPSR 20–30% below published category benchmarks.
Further reading for plaintiff law firms: Top 10 Mass Tort Marketing Agencies in 2026, How to Choose a Mass Tort Marketing Agency: 6-Criteria Framework, 21 Questions to Ask Before You Sign, and the CPSR Benchmark Report.
Frequently asked questions
There is no single "average" — mass tort settlements vary by an order of magnitude depending on tort, injury severity, exposure documentation, defendant pool, and the stage of the multidistrict litigation. Across the active mass torts in 2026, individual settlement amounts before attorney fees and liens typically range from approximately $5,000 to $300,000+, with the median individual settlement landing roughly $20,000–$75,000 on most active torts. Catastrophic-injury and wrongful-death cases routinely settle for $250,000 to several million dollars. Examples by tort: Camp Lejeune individual settlements have ranged from $10,000 to $550,000+ depending on diagnosis tier; the Roundup non-Hodgkin lymphoma settlement framework includes individual payments from approximately $5,000 to $250,000; AFFF firefighter cancer cases are reaching higher individual ranges given the occupational exposure documentation; pharmaceutical torts vary widely. Settlement amounts are claimant-specific and depend on factors no general estimate can capture.
Individual mass tort settlement amounts in 2026 typically fall in three tiers: Tier 1 — administrative or low-severity claims with documented exposure but mild injury, $1,500–$15,000; Tier 2 — moderate-severity claims with documented diagnosis and treatment, $15,000–$100,000; Tier 3 — severe injury, catastrophic harm, or wrongful death, $100,000–$1,000,000+. Where any individual claimant lands on the tier scale depends on diagnosis severity (the strongest single driver), exposure documentation quality, statute of limitations posture, the defendant's settlement pool size and structure, and whether the claim is part of an aggregate settlement framework or an individual settlement track. Mass tort settlements are negotiated either as aggregate settlements (a defendant agrees to fund a settlement pool that gets allocated across all qualifying claimants by a master matrix) or as individual settlements (case-by-case negotiation, common in MDL bellwether settlement pipelines).
Whether $100,000 is a good settlement depends on the tort, the diagnosis, the claimant's exposure documentation, and the alternatives the claimant has if they reject the offer. On torts like Camp Lejeune with strong scientific causation and broad eligible diagnoses, $100,000 falls within the published Tier 2 to lower-Tier 3 settlement range — reasonable for documented moderate-severity cases, low for catastrophic-injury cases. On torts with weaker causation or lower defendant settlement pools, $100,000 may represent the upper end of available offers. After standard 33–40% attorney contingency fees, 5–15% case costs and medical liens, the net amount the claimant receives is typically $50,000–$62,000 from a $100,000 gross. Claimants evaluating any specific settlement offer should consult their attorney about whether the offer reflects fair value for the specific diagnosis and exposure profile — general guidance from a settlement guide is no substitute for case-specific legal advice.
A $500,000 mass tort settlement, after the standard 33–40% attorney contingency fee ($165,000–$200,000), 5–15% case costs and medical liens ($25,000–$75,000), federal and state taxes on any non-physical injury portion, and any structured-settlement arrangements, typically results in a net receipt of approximately $260,000–$330,000 to the claimant. Common considerations: federal taxation generally does not apply to settlements for personal physical injury or physical sickness, but may apply to portions allocated to emotional distress without physical injury, lost wages, and punitive damages; medical liens (ERISA, Medicare, Medicaid, private insurance) must be resolved before disbursement; structured settlements can spread payments over years with tax advantages; impact on means-tested benefits (SSI, Medicaid) requires careful planning; speak with a tax professional and the settlement attorney before disbursement. This is general information, not personal financial or tax advice.
From a $50,000 mass tort settlement, the claimant typically receives approximately $25,000–$31,000 net after standard deductions. The breakdown: gross settlement $50,000; attorney contingency fee at 33–40% (the standard range, varies by state and engagement agreement) is $16,500–$20,000; case costs and medical liens at 5–15% is $2,500–$7,500; net to claimant approximately $22,500–$31,000. The exact percentages depend on the retainer agreement signed at intake, the state's contingency fee rules (some states cap fees in tort cases), and the specific lien situation. Federal income tax generally does not apply to the physical injury portion of the settlement, but applies to portions allocated to non-physical damages. The attorney handling the settlement provides a written settlement statement before disbursement that itemizes every deduction.
From a $50,000 gross mass tort settlement, the claimant typically receives a net of approximately $25,000–$31,000 after deductions: 33–40% attorney contingency fee ($16,500–$20,000), 5–15% case costs and medical liens ($2,500–$7,500). The variation is driven by the state's contingency fee rules, the specifics of the engagement agreement, and how complex the lien situation is (Medicare and Medicaid liens often require subrogation negotiation). The attorney provides a written settlement statement before disbursement itemizing every line. Net amounts are typically not taxable when the settlement compensates physical injury or physical sickness; portions allocated to emotional distress without physical injury or to punitive damages may be taxable.
Mass tort cases typically take 2–7 years from filing to individual settlement payment, with most cases settling 3–5 years after filing. The major time buckets: MDL formation and consolidation (6–18 months after the first cases file); pre-trial discovery and bellwether selection (12–24 months); bellwether trials (12–36 months); global settlement framework negotiation (6–18 months after bellwether outcomes); individual case review and allocation under the framework (6–24 months); disbursement after lien resolution (3–9 months). Active MDLs that have reached settlement framework stage as of 2026 include Roundup, 3M Combat Arms Earplugs, talcum powder, and Camp Lejeune (partial). Active MDLs in earlier stages include Hair Relaxer (MDL 3060), Ozempic/GLP-1 (MDL 3094), Bard PowerPort, and Suboxone — these will likely take 3–6 more years before claimants receive individual payments. Claimants who join an MDL late in its lifecycle often see faster payment than claimants who joined at MDL formation; claimants in still-litigating MDLs face the full timeline.
Eight factors determine the size of an individual mass tort settlement: (1) diagnosis severity — Tier 1/2/3 classification under the settlement matrix is the strongest single driver; (2) exposure documentation — medical records, prescription history, military service records, employment records all strengthen the claim; (3) timing of exposure — claims with exposure within the qualifying window receive full allocation; (4) statute of limitations posture — claims filed within the SOL receive higher allocations; (5) defendant solvency and settlement pool size — the total fund available to all claimants caps individual amounts; (6) MDL leadership negotiation outcome — the global framework structure determines per-tier ranges; (7) state of filing — some states' damages laws affect specific allocation tiers; (8) individual case factors — age, dependents, pre-existing conditions, contributing factors. Aggregate settlement matrices allocate individual amounts by formula; individual settlements negotiate case-by-case.
Mass tort settlements can affect means-tested benefits including SSI, Medicaid, and SNAP because lump-sum receipt typically counts as income or resources in the month received. The Medicare Set-Aside (MSA) requirement applies separately: claimants with Medicare eligibility (current or future) typically must establish a Medicare Set-Aside arrangement to protect Medicare's interest in future medical costs related to the injury. Mitigations claimants and their attorneys commonly consider include: structured settlement annuities (spreading payment over years to avoid lump-sum benefit disqualification); Special Needs Trusts (for claimants with disability-based benefits); careful timing of disbursement and lien resolution. Social Security retirement benefits (SSDI) are generally not affected by settlement receipt because they are insurance-based, not means-tested. This is general information; specific benefit planning requires advice from the settlement attorney plus a benefits specialist.
After a mass tort settlement framework is announced, the process typically runs: (1) defendants and plaintiff steering committee finalize the settlement agreement, which specifies tier criteria, allocation matrices, and minimum participation thresholds (often 80–95% of eligible claimants must accept for the framework to take effect); (2) claimants receive offer letters from their attorneys describing the specific tier their case has been allocated to and the gross settlement amount; (3) claimants have 30–90 days to accept or reject the offer (rejection typically returns the case to individual litigation track); (4) accepted claims enter case review for documentation verification and tier validation, which can take 60–180 days; (5) medical liens (Medicare, Medicaid, ERISA, private insurance) are resolved through subrogation negotiation, typically taking 60–180 days; (6) attorney issues a written settlement statement itemizing the gross settlement, attorney fees, case costs, lien resolutions, and net amount to claimant; (7) disbursement to claimant. The full post-announcement process typically takes 6–18 months from settlement framework announcement to claimant disbursement.
Sources and methodology
Settlement range data in this guide is drawn from publicly available sources: Multidistrict Litigation panel public filings; court-ordered settlement framework announcements; reported individual case outcomes in trade press (Law360, Reuters Legal, Bloomberg Law); IRS Publication 4345 on taxable settlement components; and Centers for Medicare & Medicaid Services guidance on Medicare Set-Aside arrangements. The guide is updated quarterly as new settlement frameworks are announced and individual case outcomes are reported.
This guide is general information about how mass tort settlements typically work. It is not legal advice and is not a substitute for case-specific guidance from a licensed attorney. Claimants with active or potential mass tort cases should consult their attorney about the specific value, timeline, and disbursement details of their case. Mass Tort Agency is a mass tort marketing agency for plaintiff law firms; we do not represent claimants and do not provide legal advice.
For law firms
Acquiring claimants for these active MDLs?
Mass Tort Agency runs exclusive lead generation campaigns across all 16+ active mass torts referenced in this guide. Book a 30-minute strategy call to review your current or prospective campaign against the 6-criteria framework.
Book the 30-min call